Sourcing from a Korean ODM? A practical checklist before you sign

Korea's ODM/OEM manufacturing base is a big reason K-beauty formulas move from concept to shelf faster than most Western supply chains manage. It's also easy to get wrong if you go in without a checklist — the manufacturing relationship is only half the job; the compliance obligations in whatever market you sell into don't transfer with the finished cases. Here's what to work through before you commit to a partner.

ODM, OEM, and private label aren't the same deal

• ODM (Original Design Manufacturer) — the manufacturer owns the formulation, often drawn from an existing base formula library, and customizes it for your brand. You get speed and lower development cost; the manufacturer usually retains rights to the base formula and may offer variants of it to other brands.

• OEM (Original Equipment Manufacturer) — you supply the formula or a detailed spec, and the manufacturer produces to it. You keep more IP control; you also carry more of the formulation and stability-testing burden yourself.

• Private label — fully off-the-shelf; only packaging and branding change. Fastest and cheapest, least differentiated.

Most K-beauty sourcing conversations start as ODM. Know which one you're actually negotiating before you talk MOQ.

What a typical ODM engagement actually looks like

The shape of the process is fairly consistent across Korean ODM houses, even though timelines vary by category:

1. Concept review — you bring a brief (texture, actives, claims, price band); the ODM proposes base formulas from its existing library that come closest.

2. Sampling rounds — usually more than one pass, adjusting texture, scent, or actives; this is where most of the calendar time goes.

3. Stability and compatibility testing — run against your actual packaging, not a generic stand-in, since a formula that's stable in one bottle isn't automatically stable in another.

4. Bulk production and QC release — confirm what QC documentation ships with the batch by default versus what you have to request.

5. Shipping and import documentation — this is where the compliance checklist below needs to already be settled, not still in progress.

What to ask before you commit

• MOQ per SKU and per shade/variant — a workable MOQ on a single shade doesn't tell you the MOQ on a five-shade range.

• Exclusivity — can the manufacturer sell the same base formula to a competing brand in your market? Get this in writing, not implied.

• Sample-to-bulk lead time — and whether stability and compatibility testing is included in that timeline or billed and scheduled separately.

• What documentation ships with the formula — full INCI declaration, certificate of analysis, stability data, microbiological test results, and (if the manufacturer prepared one) a safety assessment or product information file.

• What you own versus what you license — especially if the relationship ends and you want to move production elsewhere.

Compliance doesn't ship in the box

A Korean ODM can hand you a finished, well-tested formula and you can still be the one legally on the hook once it crosses a border. Two examples worth planning around:

• Selling into the US: under MoCRA, the "responsible person" is "the manufacturer, packer, or distributor of a cosmetic product whose name appears on the label," per FDA's MoCRA overview — and that person carries the product-listing and safety-substantiation obligations regardless of where the product was manufactured. Facility registration is a separate obligation that sits with "manufacturers and processors" distributing into the US, per FDA's registration and listing guidance — confirm with your ODM whether their facility is already registered, and get the FEI number in writing.

• Selling into the EU: "Only cosmetic products for which a legal or natural person is designated within the [Union] as 'responsible person' shall be placed on the market," per Regulation (EC) No 1223/2009, Article 4. If neither you nor your ODM has an EU-established responsible person, you don't have a route to market yet, no matter how good the formula is.

The handoff checklist

Before you schedule a first shipment, confirm you have, in hand:

1. Full INCI list in standard nomenclature, with CAS numbers.

2. Certificate of analysis for the specific batch.

3. Stability and (if applicable) preservative-efficacy test data.

4. Packaging compatibility data.

5. Written confirmation of who is the responsible person in each destination market, and whether facility registration is already in place there.

Build this into your sourcing timeline from the first sampling round, not after formulas are locked — reworking documentation after the fact costs far more than asking for it up front.

Tamats runs sourcing and compliance in the same workspace, so a formula pulled from an ODM's library gets checked against the destination market's rules — with citations — before it's on a shipping schedule. tamats.org